Donna E. Levy

2.1k total citations
24 papers, 1.5k citations indexed

About

Donna E. Levy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Donna E. Levy has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Donna E. Levy's work include Childhood Cancer Survivors' Quality of Life (6 papers), Neuroblastoma Research and Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Donna E. Levy is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (6 papers), Neuroblastoma Research and Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Donna E. Levy collaborates with scholars based in United States, Spain and United Kingdom. Donna E. Levy's co-authors include Lewis B. Silverman, Stephen E. Sallan, Richard D. Gelber, Barbara L. Asselin, Virginia Kimball Dalton, Luis A. Clavell, Harvey J. Cohen, Steven E. Lipshultz, Marshall A. Schorin and Ronald D. Barr and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Donna E. Levy

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna E. Levy United States	15	593	553	483	393	324	24	1.5k
Elly Barry United States	12	375 0.6×	399 0.7×	310 0.6×	519 1.3×	174 0.5×	24	1.2k
Jos P.M. Bökkerink Netherlands	21	645 1.1×	451 0.8×	295 0.6×	148 0.4×	125 0.4×	42	1.6k
J J Shuster United States	25	542 0.9×	448 0.8×	334 0.7×	39 0.1×	245 0.8×	34	1.6k
W. Paul Bowman United States	26	1.3k 2.3×	618 1.1×	336 0.7×	50 0.1×	218 0.7×	50	2.1k
Minnie Abromowitch United States	33	1.8k 3.0×	784 1.4×	584 1.2×	94 0.2×	333 1.0×	67	3.0k
Anders Castor Sweden	18	806 1.4×	386 0.7×	309 0.6×	43 0.1×	48 0.1×	46	1.5k
G. Henze Germany	22	1.1k 1.8×	528 1.0×	436 0.9×	24 0.1×	115 0.4×	50	1.7k
E Vélez-García United States	18	176 0.3×	80 0.1×	1.0k 2.1×	447 1.1×	531 1.6×	53	2.2k
Karel Hählen Netherlands	17	601 1.0×	375 0.7×	389 0.8×	13 0.0×	83 0.3×	31	2.1k
Clare Rowntree United Kingdom	18	1.1k 1.9×	708 1.3×	309 0.6×	14 0.0×	50 0.2×	56	1.7k

Countries citing papers authored by Donna E. Levy

Since Specialization

Citations

This map shows the geographic impact of Donna E. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna E. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna E. Levy more than expected).

Fields of papers citing papers by Donna E. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna E. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna E. Levy. The network helps show where Donna E. Levy may publish in the future.

Co-authorship network of co-authors of Donna E. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Donna E. Levy. A scholar is included among the top collaborators of Donna E. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna E. Levy. Donna E. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mascarenhas, Leo, Chitose Ogawa, Theodore W. Laetsch, et al.. (2021). Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors. Cancer Medicine. 10(3). 843–856. 2 indexed citations

Attia, Steven, Víctor M. Villalobos, Nadia Hindi, et al.. (2021). Phase (Ph) 1b/2 evaluation of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcoma (STS).. Journal of Clinical Oncology. 39(15_suppl). 11517–11517. 2 indexed citations

Martín‐Broto, Javier, Antonio López–Pousa, Andrew S. Brohl, et al.. (2020). Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Molecular Cancer Therapeutics. 20(1). 132–141. 9 indexed citations

Pelzer, Uwe, Johanna C. Bendell, Mark Womack, et al.. (2019). A phase Ib study evaluating olaratumab in combination with nab-paclitaxel and gemcitabine in first-line treatment of metastatic pancreatic cancer.. Journal of Clinical Oncology. 37(4_suppl). 330–330. 2 indexed citations

DuBois, Steven G., Brenda J. Weigel, Theodore W. Laetsch, et al.. (2018). Phase 1 study of olaratumab as monotherapy and in combination with doxorubicin, vincristine/irinotecan, or high-dose ifosfamide in pediatric patients with relapsed or refractory solid tumors: Part A results.. Journal of Clinical Oncology. 36(15_suppl). 10541–10541.

Zbrozek, Arthur S., Gary R. Hudes, Donna E. Levy, et al.. (2010). Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma. PharmacoEconomics. 28(7). 577–584. 28 indexed citations

Kearney, Susan, Suzanne E. Dahlberg, Donna E. Levy, et al.. (2009). Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitis. Pediatric Blood & Cancer. 53(2). 162–167. 122 indexed citations

Schroeck, Florian R., Leon Sun, Donna E. Levy, et al.. (2008). RACE AND PROSTATE WEIGHT AS INDEPENDENT PREDICTORS FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 179(4S). 198–198. 1 indexed citations

Bañez, Lionel L., Donna E. Levy, William J. Aronson, et al.. (2008). Risk Stratification for Biochemical Recurrence in Men With Positive Surgical Margins or Extracapsular Disease After Radical Prostatectomy: Results From the SEARCH Database. The Journal of Urology. 179(5). 1791–1796. 29 indexed citations

10.

Bañez, Lionel L., Donna E. Levy, William J. Aronson, et al.. (2008). RISK STRATIFICATION AMONG MEN WITH POSITIVE SURGICAL MARGINS OR EXTRACAPSULAR DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE. The Journal of Urology. 179(4S). 251–251. 1 indexed citations

11.

Dubey, Sarita, Patricia Stephenson, Donna E. Levy, et al.. (2006). EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1(5). 406–412. 32 indexed citations

12.

Moghrabi, Albert, Donna E. Levy, Barbara L. Asselin, et al.. (2006). Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 109(3). 896–904. 306 indexed citations

13.

Wadler, Scott, Donna E. Levy, Carla I. Falkson, et al.. (2004). A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Gynecologic Oncology. 92(3). 957–964. 39 indexed citations

14.

Lipshultz, Steven E., Nader Rifai, Virginia Dalton, et al.. (2004). The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia. New England Journal of Medicine. 351(2). 145–153. 422 indexed citations

15.

Shepard, Robert, Donna E. Levy, Jordan Berlin, et al.. (2004). Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298). Oncology. 66(4). 303–309. 26 indexed citations

16.

Silverman, Lewis B., Donna E. Levy, Virginia Kimball Dalton, et al.. (2004). Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).. Blood. 104(11). 679–679. 2 indexed citations

17.

Waber, Deborah P., Lewis B. Silverman, William J. Mautz, et al.. (2004). Outcomes of a Randomized Trial of Hyperfractionated Cranial Radiation Therapy for Treatment of High-Risk Acute Lymphoblastic Leukemia: Therapeutic Efficacy and Neurotoxicity. Journal of Clinical Oncology. 22(13). 2701–2707. 34 indexed citations

18.

Stuart, Keith, Donna E. Levy, Tom Anderson, et al.. (2003). Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group. Investigational New Drugs. 22(1). 75–81. 16 indexed citations

19.

Wadler, Scott, et al.. (2003). Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93. Journal of Clinical Oncology. 21(11). 2110–2114. 35 indexed citations

20.

Bailey, Howard H., Donna E. Levy, Julian C. Schink, et al.. (2002). A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96. Gynecologic Oncology. 85(3). 464–468. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact